tiprankstipranks
Range Impact (RNGE)
OTHER OTC:RNGE
US Market
Holding RNGE?
Track your performance easily

Range Impact (RNGE) Stock Price & Analysis

142 Followers

RNGE Stock Chart & Stats


Range Impact News

Financials

Annual

Ownership Overview

25.21%74.79%
25.21%
Insiders
― Other Institutional Investors
74.79% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

RNGE FAQ

What was Range Impact’s price range in the past 12 months?
Range Impact lowest stock price was $0.10 and its highest was $0.55 in the past 12 months.
    What is Range Impact’s market cap?
    Currently, no data Available
    When is Range Impact’s upcoming earnings report date?
    Range Impact’s upcoming earnings report date is Mar 28, 2025 which is in 81 days.
      How were Range Impact’s earnings last quarter?
      Range Impact released its earnings results on Nov 12, 2024. The company reported -$0.048 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.048.
        Is Range Impact overvalued?
        According to Wall Street analysts Range Impact’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Range Impact pay dividends?
          Range Impact does not currently pay dividends.
          What is Range Impact’s EPS estimate?
          Range Impact’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Range Impact have?
          Range Impact has 104,727,190 shares outstanding.
            What happened to Range Impact’s price movement after its last earnings report?
            Range Impact reported an EPS of -$0.048 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.846%.
              Which hedge fund is a major shareholder of Range Impact?
              Currently, no hedge funds are holding shares in RNGE
              ---

              Company Description

              Range Impact

              Vitality Biopharma, Inc. engages in unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. It operates through Pharmaceutical Operations and Clinical Operations segments. The Clinical Operations segment focuses on treating patients suffering from addiction and dependency. The Pharmaceutical Operations segment engages in research and development primarily related to the Company's cannabinoid pharmaceuticals. The company was founded by Avtar S. Dhillon and Robert T. Brooke on June 29, 2007 and is headquartered in Los Angeles, CA.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Amazon
              Apple
              Alphabet Class A
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis